On April 8, 2022, the Board of Directors of Advent Technologies Holdings, Inc. (the “Company”) appointed Lawrence Epstein to serve as a Class II director with a term expiring at the Company’s upcoming 2022 Annual Meeting of Stockholders and Christos Kaskavelis to serve as a Class III director with a term expiring at the Company’s 2023 Annual Meeting of Stockholders.
On April 8, 2022, the Board of Directors of Advent Technologies Holdings, Inc. (the “Company”) appointed Lawrence Epstein to serve as a Class II director with a term expiring at the Company’s upcoming 2022 Annual Meeting of Stockholders and Christos Kaskavelis to serve as a Class III director with a term expiring at the Company’s 2023 Annual Meeting of Stockholders.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Christos Kaskavelis was appointed as Director at ADVENT TECHNOLOGIES HOLDINGS, INC..
Action
appointed
Role
Director
Exact text from the filing
On April 8, 2022, the Board of Directors of Advent Technologies Holdings, Inc. (the “Company”) appointed Lawrence Epstein to serve as a Class II director with a term expiring at the Company’s upcoming 2022 Annual Meeting of Stockholders and Christos Kaskavelis to serve as a Class III director with a term expiring at the Company’s 2023 Annual Meeting of Stockholders.
Lawrence Epstein was appointed as Director at ADVENT TECHNOLOGIES HOLDINGS, INC..
Action
appointed
Role
Director
Exact text from the filing
On April 8, 2022, the Board of Directors of Advent Technologies Holdings, Inc. (the “Company”) appointed Lawrence Epstein to serve as a Class II director with a term expiring at the Company’s upcoming 2022 Annual Meeting of Stockholders and Christos Kaskavelis to serve as a Class III director with a term expiring at the Company’s 2023 Annual Meeting of Stockholders.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.